MJardin Group, Inc. Stock Canadian Securities Exchange
Equities
MJAR
CA60689X1096
Pharmaceuticals
Sales 2019 | 26.7M 36.49M | Sales 2020 | 11.44M 15.63M | Capitalization | 3.41M 4.66M |
---|---|---|---|---|---|
Net income 2019 | -267M -365M | Net income 2020 | -34M -46.47M | EV / Sales 2019 | 5.55 x |
Net Debt 2019 | 134M 183M | Net Debt 2020 | 164M 224M | EV / Sales 2020 | 14.6 x |
P/E ratio 2019 |
-0.06
x | P/E ratio 2020 |
-0.1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 92.27% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 19-10-31 |
Patrick Witcher
BRD | Director/Board Member | - | 19-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Blair Jordan
BRD | Director/Board Member | 55 | 21-05-25 |
James Lowe
BRD | Director/Board Member | - | 19-05-05 |
1st Jan change | Capi. | |
---|---|---|
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |